Process, assays, testing and formulation
Ended Definitive Contract Awarded Last action
- Contract number
- W911QY12C0028
- Awardee
-
Catalent Maryland, Inc. UEI UBMBZUF5VMV4
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $19,609,566
Award facts
- Opportunity
-
- W911QY11R0039 Solicitation number
- Delivery of a current Good Manufacturing Practices (cGMP) trivalent filovirus vaccine using the Venezuelan Equine Encephalitis (VEE) Replicon Particle (VRP) system Award Notice · Posted Jun 7, 2011
- Contract value 58% obligated
-
- $19,659,142.09 Current, with exercised options
- $33,966,492.39 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Incentive
- Place of performance
- Baltimore, MD 21201, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$49,576 | |
| Terminate for Convenience | $1,768,535 | |
| Supplemental Agreement for work within scope | -$496,963 | |
| Other Administrative Action | -$4,382,349 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $2,500,000 | |
| Other Administrative Action | $5,000,000 | |
| Supplemental Agreement for work within scope | $1,000,000 | |
| Supplemental Agreement for work within scope | -$1,135,239 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $6,600,000 | |
| Change Order | $0 | |
| Other Administrative Action | $900,000 | |
| Other Administrative Action | $2,000,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $2,025,158 | |
| Other Administrative Action | $3,600,000 | |
| Original award | $280,000 |
Show all 19
About this award
This is a $33,966,492.39 cost plus incentive Definitive Contract awarded by the Joint Program Executive Office for Chemical and Biological Defense, a U.S. Defense agency, to Catalent Maryland, Inc. (doing business as Paragon Biosciences) on December 28, 2011. The contract is for "PROCESS, ASSAYS, TESTING AND FORMULATION" and has a period of performance through June 15, 2016. The contract was not set aside for a small business. The place of performance is Baltimore, Maryland.
Quick answers
Who was awarded contract W911QY12C0028?
W911QY12C0028 was awarded to Catalent Maryland, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on December 28, 2011.
How much is contract W911QY12C0028 worth?
The government has obligated $19,609,566 on W911QY12C0028. Its current value, with exercised options, is $19,659,142. Its potential value, with all options, is $33,966,492.
Which agency awarded contract W911QY12C0028?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY12C0028, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY12C0028 competed?
The extent of competition for W911QY12C0028 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award